Skip to search formSkip to main contentSkip to account menu

Speaking in Italics

The Slide Rule

View via Publisher (opens in a new tab)

Hundreds and Millions

Compliance Issues Associated with Overcoming 'Friction' in the Sale of Expensive Pharmaceutical Products

  • Gregg Shapiro
  • Business, Medicine
    SSRN Electronic Journal
  • 15 December 2020
A survey of compliance issues that may arise in the distribution and sale of expensive pharmaceutical products finds that some firms may be reluctant to comply with anti-doping regulations.
View via Publisher (opens in a new tab)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)